Qoly Corporation

Yohei is one of the five founders of the Qoly and acting as a CEO. Before Qoly, he led the surgical robotics research team at the Sony overseeing R&D and commercialization strategies for over a decade, following an extensive career by launching several new consumer products across the multiple divisions. He had also driven numerous open innovation initiatives across the divisions and collaboration activities with hospitals and industry partners globally. Leveraging these experiences and strategic assets, he led the spin-out initiatives from the Sony to establish the Qoly Corporation in 2025.

Close

Kazuhito is a Co-Founder and the CTO of Qoly, where he led the development of the technology that became Qoly's core IP during his tenure in robotics R&D at Sony. He is the architect of Qoly’s technical competitive advantage, holding numerous key patents for proprietary mechanical designs. A recipient of the prestigious 2025 Sony Outstanding Engineer Award, he co-founded the company in 2025. He leads the development of innovative products that deliver value to both patients and physicians by extracting true clinical pain points through direct dialogue with surgeons.

Close

Atsushi is a Co-Founder and Chief People Officer at Qoly. Since co-founded Qoly in 2025, he has been responsible for building the strong networks with the Key Opinion Leaders (KOLs) rapidly to integrate the clinical evaluations into the product development. Before Qoly, he experienced in depth about the engineering and the clinical immersion with over 20 years at the medical robotics development at Sony. He also completed the medical curriculum at Tokyo Women’s Medical University, giving him a deep expertise of the clinical engineering. Additionally, he leverages his extensive management skills of the organizational culture and team building to ensure a diverse workforce and to maximize the potential of the organization.

Close

Naoki began his career at Deloitte and went on to serve in CFO and senior finance leadership roles across multiple private and publicly listed companies, including several in the medical device and biotech sectors. He has led two successful IPOs on the Tokyo Stock Exchange and brings extensive experience in capital markets, strategic financing, corporate restructuring, and cross-border fundraising.　In February 2026, he joined Qoly as a founding executive team member to help scale the company’s global business and financial platform. He is responsible for corporate finance strategy, investor relations, and building the financial infrastructure necessary to accelerate Qoly’s commercialization. He holds an MBA from Hitotsubashi University.

Close

Managing Partner at Fast Track Initiative (FTI). As Managing Partner, Dr. Anzai oversees deal sourcing, seed investment, execution, business development, and exits within the biotech and medtech sectors. He has over 20 years of experience in company creation and hands-on support for ventures built on university research. Prior to FTI, he was with Arthur D. Little, where he advised pharmaceutical, diagnostics, and research equipment companies on management and R&D strategy. He holds a Ph.D. in Life Sciences from the University of Tokyo and completed the MIT Sloan AMP.

Close

Hajime has over 25 years of medical device industry experience and is known as a leading venture capitalist in medical device in Japan. He spent five years at a Silicon Valley based VC, leading several companies to exits with valuations exceeding USD 1 billion. In 2013, he founded MedVenture Partners, Inc., a VC fund focused on medical device. Over the past 12 years, he has raised three funds totaling more than USD 200M. His notable track records include (US) Fox Hollow Technologies, Cardiovascular Systems, Chestnut Medical, Arrinex, Companion Medical, Beta Bionics, (JAPAN) A-Traction, Biomedical Solutions, etc. At Qoly, he leads overall management strategy, regulatory affairs, and fundraising.

Close

Capitalist at Fast Track Initiative. After earning her medical degree and completing clinical training in underserved regions, Dr. Mori practiced cardiology at Tokyo Women’s Medical University Hospital. During her tenure, she was involved in clinical trials for medical device startups, contributing to the social implementation of medical technology from a clinical perspective. She currently supports medtech and healthtech ventures from both medical and management viewpoints. She is a Board Certified Member of the Japanese Society of Internal Medicine and a Certified Occupational Physician. She holds an MBA from the University of Michigan’s Ross School of Business.

Close